Synbio Technologies

Synbio Technologies Empowering scientific discoveries with advanced DNA manufacturing and design solutions.

Synbio Technologies was founded in August of 2013 with the hopes of becoming one of the premier companies within the synthetic biology industry. In order to accomplish this goal, many hurdles were circumvented to continue to move forward and offer our customers the highest quality product possible. By striving to move forward in this industry we have fine-tuned our mechanisms of various synthetic

biological applications and continue to do so on a daily basis. This is because we strive to be on the cutting edge of this technology which has led us to make groundbreaking discoveries within this field. In doing so we have developed the world’s first GPS Platform, including genotype, phenotype and synotype. The GPS Platform is what separates us from the rest of the competition within this industry. This platform is broken down into three portions and when combined offers a one stop solution of gene “design-construction-application” process. This streamlined process allows us to offer our customers a unique experience when designing their gene of interest in order to comply with the research interests. In addition to our technologically advanced synthetic biology applications there are hundreds of professionals with experienced track records of success in scientific research and industrial management. We are proud to have such a devoted staff with one goal in mind: to offer our customers with the highest quality product possible within an efficient time-frame. Our staff has perfected and streamlined many of these biological applications in order to comply with our customer’s demands. Please contact us with any questions you may have about our various services that we are currently offering.

🧠🔬 RESEARCH SPOTLIGHT | Nature NeuroscienceA new study using STARFISH visualized endogenous mRNA translation with single...
09/11/2026

🧠🔬 RESEARCH SPOTLIGHT | Nature Neuroscience

A new study using STARFISH visualized endogenous mRNA translation with single-molecule sensitivity and near-codon-level resolution, revealing that tau is translated in neuronal dendrites and that ~1/3 of newly synthesized tau is degraded by the neuroproteasome.

🧪 Synbio Technologies supported the research through STARFISH probe synthesis, including Tetrazine and Azide click-chemistry handles for efficient labeling and conjugation.

📖 Read the paper:
https://hubs.la/Q04xcSGd0

Explore our Click Chemistry Services for customized probe labeling and conjugation:
https://hubs.la/Q04xcSr-0

🧬 AAV Quality Check: More Than Just TiterWhen working with AAV vectors, reliable quality starts with consistent analytic...
09/10/2026

🧬 AAV Quality Check: More Than Just Titer
When working with AAV vectors, reliable quality starts with consistent analytical characterization. 🔬📊

In our recent AAV case study, we evaluated:
🧪 VG titer
Measured using an internationally common VG titer detection method as the basis for release titer.
🔬 Capsid protein profile
SDS-PAGE showed clear VP1, VP2, and VP3 bands with a VP1:VP2:VP3 ratio of approximately 1:1:10.
✨ Purity
The sample demonstrated >98% purity with compliant protein abundance levels.
These analytical results provide useful insight into vector quality, capsid integrity, and batch consistency. 🧬

Reliable characterization is an important step toward reproducible AAV-based research.
https://hubs.la/Q04x6b1J0

🔥 TRENDING IN DRUG DISCOVERY🤖 AI is generating potential drug candidates faster than ever—but can experimental labs keep...
09/09/2026

🔥 TRENDING IN DRUG DISCOVERY

🤖 AI is generating potential drug candidates faster than ever—but can experimental labs keep up? 🔬

This is creating a new bottleneck: validation.
From functional screening to safety, developability, and translational studies, researchers still need to determine which AI-designed molecules are truly worth advancing. 🧪

The emerging model:
🤖 AI → 🧪 Experiment → 📊 Data → 🔄 Better Design
More candidates don’t necessarily mean better drugs.
The key is finding the right ones faster. ⚡
https://hubs.la/Q04w_Z1-0
https://hubs.la/Q04w_Z0p0

🧬 What makes a high-quality dual-sgRNA library?A dual-sgRNA library is not simply a single-sgRNA library with an additio...
09/08/2026

🧬 What makes a high-quality dual-sgRNA library?

A dual-sgRNA library is not simply a single-sgRNA library with an additional guide.
The expression strategy matters. 🔬

At Synbio Technologies, we use a dual-promoter strategy to independently drive the expression of two sgRNAs, helping build a more robust foundation for dual-sgRNA screening libraries.
📌 Our case study:
🎯 99.12% coverage
📊 2.8-fold uniformity

These results highlight how careful library design can translate into strong library quality and consistent representation.

Dual-sgRNA libraries can support a range of research applications, including functional genomics, genome-wide screening, gene knockout, target validation, and drug discovery. 🧪💊
https://hubs.la/Q04wVg1G0

🚀 Exploring an RNA-based project? The right RNA strategy starts with the right design.🧬 RNA isn’t just one technology—it...
09/07/2026

🚀 Exploring an RNA-based project? The right RNA strategy starts with the right design.

🧬 RNA isn’t just one technology—it’s a toolbox!
Depending on your research goal, different RNA molecules can play very different roles:
🔇 siRNA — silence specific genes
🧩 miRNA — regulate gene expression
✂️ ASOs — modulate RNA targets
🧪 IVT RNA — produce functional RNA in vitro
🎯 sgRNA — guide targeted genome editing

So, what matters when working with RNA?
👉 Sequence design
👉 Purity & consistency
👉 Chemical modifications
👉 Synthesis strategy

From high-purity siRNA, miRNA, and ASOs to custom IVT RNA and AI-powered sgRNA design, we provide RNA solutions tailored to different research needs. 🧪🔬
https://hubs.la/Q04wQHR10

🧬 rHuPH20: The “Molecular Scissors” Behind Faster Subcutaneous Drug DeliveryWhy do some biologics require long IV infusi...
09/04/2026

🧬 rHuPH20: The “Molecular Scissors” Behind Faster Subcutaneous Drug Delivery

Why do some biologics require long IV infusions while others can be delivered in just a few minutes?

The answer partly lies in hyaluronic acid (HA), which forms a dense, hydrated matrix beneath the skin.

🔬 rHuPH20 temporarily breaks down HA at the injection site, helping therapeutic molecules spread more efficiently through subcutaneous tissue.

The effect is local, temporary, and reversible, making rHuPH20 an interesting tool for drug-delivery research.

For protein researchers, it also highlights the importance of protein design, glycosylation, expression systems, and functional activity.
https://hubs.la/Q04wt1sB0

🧬 Working with a challenging DNA sequence?For complex gene synthesis, getting the sequence ordered is just the beginning...
09/03/2026

🧬 Working with a challenging DNA sequence?
For complex gene synthesis, getting the sequence ordered is just the beginning.

Difficult regions, high or low GC content, repeats, and long constructs can all affect synthesis and downstream work.

At Synbio Technologies, we bring sequence design, optimization, synthesis, cloning, and QC together in one workflow—helping researchers move from a challenging sequence to a research-ready construct.

Whether you're working with a long construct, multi-gene design, or a sequence that needs extra technical review, our team can help evaluate the project and identify a practical path forward.

🔥 Fall Promotion | Sep 1–30, 2026
Complex Sequences — 53% OFF

Have a sequence you're working on? Let's talk.
https://hubs.la/Q04wtfzk0

🧬 How far can sequential genome editing go?From sgRNA design to clone validation, each step matters. 🔬In a real-world E....
09/02/2026

🧬 How far can sequential genome editing go?
From sgRNA design to clone validation, each step matters. 🔬

In a real-world E. coli intestinal isolate, our researchers used the pCas + pTargetF dual-plasmid system to complete:
🔹 7 consecutive editing rounds
🔹 7 genomic loci
🔹 36 kb of precisely integrated DNA
🔹 3 complete genes
🔹 No irreversible growth defects
🔹 Successful plasmid curing & PCR validation

💡 The system supports knockout, knock-in, replacement, and multi-site sequential editing.
A powerful example of scalable genome engineering in action. 🧬⚙️
https://hubs.la/Q04wcC700

📚 Back to school, back to the lab!A new semester means new ideas, new experiments, and new research goals. 🔬Wishing all ...
09/01/2026

📚 Back to school, back to the lab!

A new semester means new ideas, new experiments, and new research goals. 🔬
Wishing all researchers, students, and scientists a productive and inspiring fall!

To help you power up your research, Synbio Technologies is bringing you Back-to-School Savings all September.
🎓 Sep 1–30, 2026
💡 More ways to save on your research essentials.

Start the semester strong and make your next experiment count!
https://hubs.la/Q04w2mc50

🧪 Plasmid DNA Prep Made Simple—and AffordableLooking for reliable, high-quality plasmid DNA for your next experiment?For...
08/31/2026

🧪 Plasmid DNA Prep Made Simple—and Affordable
Looking for reliable, high-quality plasmid DNA for your next experiment?
For a limited time, get 100 µg of transfection-grade plasmid DNA for just $69.

You can count on:
✅ >85% supercoiled DNA
✅ Low endotoxin
✅ U.S.-based manufacturing
✅ Consistent quality for downstream applications

Perfect for:
🧬 Cell transfection
🦠 Viral vector production
🔬 Gene editing workflows
🧪 Protein expression & antibody production
📩 https://hubs.la/Q04vR40s0

Address

9 Deer Park Drive , Suite J-25
Monmouth Junction, NJ
08852

Opening Hours

Monday 8:30am - 5:30pm
Tuesday 8:30am - 5:30pm
Wednesday 8:30am - 5:30pm
Thursday 8:30am - 5:30pm
Friday 8:30am - 5:30pm

Telephone

+17322303003

Alerts

Be the first to know and let us send you an email when Synbio Technologies posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Synbio Technologies:

Shortcuts

Share